The Food and Drug Administration (FDA) has approved a breast implant for women undergoing reconstructive or revision surgery.
The Natrelle Inspira SoftTouch, from global pharmaceutical company Allergan, is a medium-firm cohesive implant. The FDA approved Natrelle for breast augmentation with silicone-filled implants in women aged 22 years or older. It has also granted approval to the implant line for augmentation with saline-filled implants in women age 18 and older.
"Adding Natrelle Inspira SoftTouch breast implants to our already robust line of offerings gives Allergan the most extensive variety of implants in the industry and provides doctors with a wide range of options," said David Nicholson, chief research and development officer of Allergan.
Nicholson added, "Now, the Inspira line of breast implants helps physicians to better meet diverse, patient-specific needs based on available breast tissue and desired outcomes.”